309 related articles for article (PubMed ID: 18571765)
1. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer.
Zhang S; Qiu X; Gu Y; Wang E
Lung Cancer; 2008 Dec; 62(3):295-301. PubMed ID: 18571765
[TBL] [Abstract][Full Text] [Related]
2. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of focal adhesion kinase in non-small cell lung cancer.
Carelli S; Zadra G; Vaira V; Falleni M; Bottiglieri L; Nosotti M; Di Giulio AM; Gorio A; Bosari S
Lung Cancer; 2006 Sep; 53(3):263-71. PubMed ID: 16842883
[TBL] [Abstract][Full Text] [Related]
4. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
8. Higher expression of RhoC is related to invasiveness in non-small cell lung carcinoma.
Shikada Y; Yoshino I; Okamoto T; Fukuyama S; Kameyama T; Maehara Y
Clin Cancer Res; 2003 Nov; 9(14):5282-6. PubMed ID: 14614010
[TBL] [Abstract][Full Text] [Related]
9. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.
Sun CK; Ng KT; Sun BS; Ho JW; Lee TK; Ng I; Poon RT; Lo CM; Liu CL; Man K; Fan ST
Br J Cancer; 2007 Jul; 97(1):50-7. PubMed ID: 17551499
[TBL] [Abstract][Full Text] [Related]
10. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
Chang GC; Liu KJ; Hsieh CL; Hu TS; Charoenfuprasert S; Liu HK; Luh KT; Hsu LH; Wu CW; Ting CC; Chen CY; Chen KC; Yang TY; Chou TY; Wang WH; Whang-Peng J; Shih NY
Clin Cancer Res; 2006 Oct; 12(19):5746-54. PubMed ID: 17020980
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
[TBL] [Abstract][Full Text] [Related]
12. Elevated activities of MMP-2 in the non-tumorous lung tissues of curatively resected stage I NSCLC patients are associated with tumor recurrence and a poor survival.
Kim SH; Choi HY; Lee J; Son DS; Lee HS; Song IS; Lim YS; Hong YS; Kim J; Choi YS
J Surg Oncol; 2007 Mar; 95(4):337-46. PubMed ID: 17326127
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
Hsu CP; Shen GH; Ko JL
Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of MAPK in non-small cell lung cancer].
Zhang ZF; Ma JQ; Zhang L
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):339-42. PubMed ID: 15854513
[TBL] [Abstract][Full Text] [Related]
15. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
16. [Detection of telomerase activity level in human non-small-cell lung cancer].
Yang HZ; Hu CP; Su XL
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):549-50. PubMed ID: 12536537
[TBL] [Abstract][Full Text] [Related]
17. [The role of Smad4 and MAPK proteins in signal transduction pathway in non-small cell lung cancer].
Tong XD; Liu HX; Zhao HR; Xu SG; Li Y; Han LB; Zhang L
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):741-5. PubMed ID: 17366784
[TBL] [Abstract][Full Text] [Related]
18. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC).
Karg A; Dinç ZA; Başok O; Uçvet A
Pathol Res Pract; 2006; 202(8):577-83. PubMed ID: 16814944
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
Chen XF; Zhang HT; Qi QY; Sun MM; Tao LY
Lung Cancer; 2005 Apr; 48(1):69-76. PubMed ID: 15777972
[TBL] [Abstract][Full Text] [Related]
20. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
